Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15474704rdf:typepubmed:Citationlld:pubmed
pubmed-article:15474704lifeskim:mentionsumls-concept:C0038027lld:lifeskim
pubmed-article:15474704lifeskim:mentionsumls-concept:C0004595lld:lifeskim
pubmed-article:15474704lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:15474704lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:15474704pubmed:issue31-32lld:pubmed
pubmed-article:15474704pubmed:dateCreated2004-10-11lld:pubmed
pubmed-article:15474704pubmed:abstractTextRecombinant Bacillus subtilis spores were employed as a vaccine delivery system in a heterologous mucosal priming-parenteral boosting vaccination strategy in the mouse model. BALB/c and C57BL/6 mice were orally immunised with recombinant spores expressing tetanus toxin fragment C (TTFC) fused to the spore outer coat protein CotB, and then subcutaneously boosted with soluble TTFC (without adjuvant). Two weeks after boosting, a significantly higher serum TTFC-specific IgG response was stimulated in mice primed with recombinant spores (antibody concentration of 2600 +/- 915 in C57BL/6 and 1200 +/- 370 ng/ml in BALB/c) compared to mice inoculated with wild type spores (650 +/- 250 and 250 +/- 130 ng/ml, respectively). IgG subclass analysis showed a prevalence of IgG1 and IgG2b, indicative of a Th2 type of immune response. Oral administration of recombinant spores stimulated also a significant local TTFC-specific IgA response. These data show that recombinant spores of B. subtilis are able to prime the immune system by the oral route, and that a combined mucosal/parenteral strategy can stimulate both local and systemic antigen-specific immune responses.lld:pubmed
pubmed-article:15474704pubmed:languageenglld:pubmed
pubmed-article:15474704pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15474704pubmed:citationSubsetIMlld:pubmed
pubmed-article:15474704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15474704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15474704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15474704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15474704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15474704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15474704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15474704pubmed:statusMEDLINElld:pubmed
pubmed-article:15474704pubmed:monthOctlld:pubmed
pubmed-article:15474704pubmed:issn0264-410Xlld:pubmed
pubmed-article:15474704pubmed:authorpubmed-author:OggioniMarco...lld:pubmed
pubmed-article:15474704pubmed:authorpubmed-author:PozziGianniGlld:pubmed
pubmed-article:15474704pubmed:authorpubmed-author:CiabattiniAnn...lld:pubmed
pubmed-article:15474704pubmed:authorpubmed-author:IsticatoRache...lld:pubmed
pubmed-article:15474704pubmed:authorpubmed-author:ParigiRiccard...lld:pubmed
pubmed-article:15474704pubmed:issnTypePrintlld:pubmed
pubmed-article:15474704pubmed:day22lld:pubmed
pubmed-article:15474704pubmed:volume22lld:pubmed
pubmed-article:15474704pubmed:ownerNLMlld:pubmed
pubmed-article:15474704pubmed:authorsCompleteYlld:pubmed
pubmed-article:15474704pubmed:pagination4139-43lld:pubmed
pubmed-article:15474704pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:meshHeadingpubmed-meshheading:15474704...lld:pubmed
pubmed-article:15474704pubmed:year2004lld:pubmed
pubmed-article:15474704pubmed:articleTitleOral priming of mice by recombinant spores of Bacillus subtilis.lld:pubmed
pubmed-article:15474704pubmed:affiliationLaboratorio di Microbiologia Molecolare e Biotecnologia (LAMMB), Dipartimento di Biologia Molecolare, Università di Siena, Policlinico Le Scotte V lotto, piano 1, 53100 Siena, Italy.lld:pubmed
pubmed-article:15474704pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15474704pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15474704lld:pubmed